Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine for Negative Symptoms in Schizophrenia
NCT00222794Phase 4Completed
- Sponsor
- University of Pittsburgh
- Start
- Nov 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atomoxetine in schizophrenia, schizoaffective disorder, sponsored by University of Pittsburgh. Started Nov 2003; status: completed.
02
Drugs
atomoxetine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00222794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00222794.